Table 4.
Case | Time from onset to CSF collection (days) | Sample volume (µl) | Specific reads (bp) | Genomic coverage (%) | Relative abundance (%) | Depth (X) | Proportion of human host sequences (%) |
---|---|---|---|---|---|---|---|
1 | 35 | 500 | 266 | 0.53 | 3.32 | 1.15 | 99.85 |
2 | 60 | 500 | 448 | 0.87 | 1.17 | 1.2 | 96.03 |
3 | 180 | 500 | 8 | 0.02 | 0.48 | 1.1 | 99.47 |
4 | 30 | 500 | 86 | 0.20 | 82.40 | 1.08 | 99.95 |
5 | 365 | 500 | 116 | 0.13 | 3.47 | 1.24 | 99.27 |
6 | 15 | 500 | 126 | 0.26 | 7.17 | 1.11 | 99.65 |
7 | 540 | 500 | 264 | 0.57 | 3.79 | 1.06 | 99.70 |
8 | 17 | 500 | 72 | 0.14 | 0.13 | 1.19 | 73.85 |
CSF cerebrospinal fluid, NB neurobrucellosis